Xcellerant Ventures
  • Portfolio
  • Team
  • About
  • Invest
  • News
  • Contact
Select Page
This Startup Can Improve Cancer Screenings, Starting With Mammograms

This Startup Can Improve Cancer Screenings, Starting With Mammograms

by Xcellerant Ventures | Dec 19, 2023 | Portfolio Company News

Origionally posted on Forbes.com: https://www.forbes.com/sites/evaepker/2023/12/19/this-startup-can-improve-cancer-screenings-starting-with-mammograms/?sh=2aed40eacae4   Starting just this past March, countless women received a note after their mammogram that...
Barco Announces Partnership with DeepLook Medical for Breast Cancer AI Tool

Barco Announces Partnership with DeepLook Medical for Breast Cancer AI Tool

by Xcellerant Ventures | Nov 20, 2023 | Portfolio Company News

Origionally posted on Barco’s Website: https://www.barco.com/fr/about/press-releases/barco-announces-introduction-of-ai-technology-for-visualization-of-dense-breast-tissue   Barco’s colorful high-resolution monitors burst with more data than ever before...
FDA Clears One-Click Segmentation & Measurement Tool

FDA Clears One-Click Segmentation & Measurement Tool

by Xcellerant Ventures | Jul 8, 2021 | Portfolio Company News

Origionally posted on DeepLook Medical’s Website: https://www.deeplookmedical.com/post/fda-clears-one-click-segmentation-measurement-tool   The FDA has granted 510(k) clearance for DL PreciseTM, our one-click tool to automate segmentation and measurement of...
Next Entries »

Recent Posts

  • TruLite Health Partners with Lee Health to Elevate Health Equity Strategy
  • TruLite Health Selected for Microsoft Pegasus Program
  • Xcellerant Ventures Leads DeepLook Medical’s Series A Round
  • DeepLook Medical’s DL Precise™ improved the performance of the breast imaging department with 12% favorable change in recall rates
  • Feasibility Study Evaluates Potential of Digital Health Platform to Help Patients Manage Prostate Cancer Symptoms

Recent Comments

No comments to show.
  • Portfolio
  • Team
  • About
  • Invest
  • News
  • Contact
  • Privacy Policy
© Xcellerant Ventures 2023